top
Search terms
Results 1 - 4 of 4 - ordered by :
Epeuropace

Temporal changes in patient characteristics and prior pharmacotherapy in patients undergoing radiofrequency ablation of atrial fibrillation: a Danish nationwide cohort study Introduction ...

Europace, Ablation for atrial fibrillation, Deniz Karasoy, Gunnar Hilmar Gislason, Jim Hansen, Jonas Bjerring Olesen, Christian Torp-Pedersen, Arne Johannessen, Morten Lock Hansen

Date : 01/05/2013 Item size : 265706 bytes
Epeuropace

The methylmercury as an industrial and trade waste was no more emitted in the surrounding ocean from the 1960s onward.1 There is no methylmercury contamination at any where in Japan after the ...

Europace, Letter to the Editor, Masayuki Shimano, Rei Shibata, Yukiomi Tsuji, Yasuya Inden, Toyoaki Murohara

Date : 01/12/2008 Item size : 118826 bytes
Epeuropace

Methods and results The numbers of circulating CD34+/KDR+ EPCs were determined with flow cytometry in 51 consecutive patients with persistent AF [the mean age: 67 ± 1.3 years, male (65%)] prior to ...

Europace, Atrial Fibrillation - Clinical Issues, Chung-Wah Siu, Timothy Watson, Wing-Hon Lai, Yee-Ki Lee, Yap-Hang Chan, Kwong-Man Ng, Chu-Pak Lau, Gregory Y.H. Lip, Hung-Fat Tse

Date : 01/04/2010 Item size : 238752 bytes
Epeuropace

Important risk factors for atrial fibrillation are hypertension, heart failure, diabetes mellitus, a history of myocardial infarction, valvular disease, obesity, smoking of cigarettes, and ...

Europace, Editorial, Jan Heeringa

Date : 01/04/2010 Item size : 127624 bytes